Partial tetrasomy 12pter-12p12.3 in a girl with Pallister-Killian syndrome: extraordinary finding of an analphoid, inverted duplicated marker

Eur J Hum Genet. 2001 Aug;9(8):572-6. doi: 10.1038/sj.ejhg.5200673.

Abstract

Cytogenetic analysis in a girl with multiple congenital anomalies indicating Pallister-Killian syndrome (PKS) showed a supernumerary marker chromosome in 1/76 lymphocytes and 34/75 fibroblast metaphases. GTG-banding pattern was consistent with the chromosomal region 12pter-12q11. While fluorescence-in-situ hybridisation (FISH) with a whole chromosome 12 painting probe confirmed the origin of the marker, a chromosome 12 specific alpha-satellite probe did not hybridise to it. FISH analysis with a specific subtelomeric probe 12p showed hybridisation to both ends of the marker chromosome. High-resolution multicolour-banding (MCB) studies revealed the marker to be a der(12)(pter-->p12.3::p12.3-->pter). Summarising the FISH information, we defined the marker as an inverted duplication of 12pter-12p12.3 leading to partial tetrasomy of chromosome 12p. In skin fibroblasts, cultured at the patient's age of 1 year and 9 years, the marker chromosome was found in similar frequencies, even after several culture passages. Therefore, we consider the marker to have a functional centromere although it lacks detectable centromeric alpha-satellite sequences. To the best of our knowledge, this is the first proven analphoid marker of chromosome 12. Molecular genetic studies indicated that this marker is of paternal origin. The finding of partial tetrasomy 12pter-12p12.3 in our PKS patient allows to narrow down the critical region for PKS.

Publication types

  • Case Reports

MeSH terms

  • Abnormalities, Multiple / genetics*
  • Aneuploidy*
  • Child
  • Child, Preschool
  • Chromosome Inversion*
  • Chromosomes, Human, Pair 12 / genetics*
  • Craniofacial Abnormalities / genetics
  • Female
  • Fingers / abnormalities
  • Genetic Markers / genetics*
  • Humans
  • Infant
  • Infant, Newborn
  • Skull / abnormalities
  • Syndrome

Substances

  • Genetic Markers